Addiction Treatment
Addiction Treatment RSS Feed RSS

Applying Dialectical Behavior Therapy to Addiction

August 1, 2016
Dialectical behavior therapy (DBT) is well-known for treating borderline personality disorder (BPD) and individuals at high risk for suicide. Two studies have shown that DBT has really good outcomes in terms of reducing substance use. In this interview, Dr. Linehan shares her knowledge of DBT as a treatment method for addiction.
Read More

Reports of Gabapentin Misuse and Abuse Appear to Be True

August 1, 2016
Bret A. Moore, PsyD, ABPP
Bret A. Moore, PsyD, ABPP Board-Certified Clinical Psychologist, San Antonio, TX Dr. Moore has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Gabapentin is FDA-approved for seizures and neuropathic pain, but it’s commonly used off-label for a variety of psychiatric and physical conditions, including anxiety, insomnia, borderline personality disorder, alcohol use disorders, and multiple pain disorders. Another aspect of gabapentin use that has come to light in recent years is a seemingly pervasive pattern of misuse and abuse.
Read More
CLINICAL Q&A

Using Motivational Interviewing in Your Practice

June 1, 2016
David Rosengren, PhD

David Rosengren, PhD. President of Prevention Research Institute, Inc.
Dr. Rosengren has disclosed that he receives book royalties from Guilford Press. Dr. Carlat has reviewed this article and found no evidence of bias in this educational activity.

At its most basic, motivational interviewing is a conversation in which you are trying to help someone deal with ambivalence that prevents them from acting on a problematic behavior. At a more complex level, it has to do with things like paying attention to how the patient talks and what kind of language they’re using. In this interview, Dr. Rosengren discusses the language and process of motivational interviewing.
Read More
RESEARCH UPDATE

Psychedelic Mushrooms May Help Treatment Resistant Depression

June 1, 2016
Bret A. Moore, PsyD, ABPP
Bret A. Moore, PsyD, ABPP

Board-Certified Clinical Psychologist, San Antonio, TX

Dr. Moore has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Psilocybin, a naturally occurring and psychedelic compound of the Psilocybe species of mushrooms, has garnered the most attention.
Psilocybin is essentially a serotonin 2A agonist. Theoretically, this action should mediate depressive symptoms, but we don’t know for sure because no available antidepressants are direct agonists of this receptor. Researchers from the United Kingdom set out to see if this is indeed the case.
Read More
RESEARCH UPDATE

Good News for Smoking Cessation Drugs: Not as Scary as Once Thought

June 1, 2016
Bret A. Moore, PsyD, ABPP

Bret A. Moore, PsyD, ABPP                                    

Board-Certified Clinical Psychologist, San Antonio, TX.                                       

Dr. Moore has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Both varenicline (Chantix) and bupropion (Zyban) are effective anti-smoking agents, but over the years we’ve heard about potential neuropsychiatric side effects, especially related to varenicline. These include depression, suicidal thoughts, psychosis, and nightmares.
Read More
CLINICAL UPDATE

Medication Treatment of Anxiety Disorders in Substance Abusers

May 1, 2016
Daniel Carlat, MD
Daniel Carlat, MD  

Editor-in-Chief, Publisher, The Carlat Report.

Dr. Carlat has disclosed that he has no relevant relationships or financial interests in any commercial company pertaining to this educational activity.

While benzodiazepines are effective anti-anxiety workhorses for many patients, most guidelines tell us to avoid prescribing them to substance abusers. The concern is that the benzo high will remind patients of their substances of choice, and that benzo withdrawal symptoms will lead to old substance abuse habits.
Read More
EXPERT Q&A

Benzodiazepines: Dependence, Tolerance, and Addiction

May 1, 2016
Alex Stalcup, MD

DrStalcup_headshot.jpgAlex Stalcup, MD
Medical director of the New Leaf Treatment Center in Lafayette, CA.
Dr. Stalcup has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this
educational activity.

One good way to think of benzodiazepines is that they are literally, physiologically anyway, alcohol in a pill. Especially the fast-onset/fast-offset benzodiazepines like alprazolam (Xanax) have a very similar pharmacologic profile to alcohol. This discussion with Dr. Alex Stalcum covers strategies of using benzodiazepines as anxiety treatments for substance-abusing patients.
Read More
Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
Featured Video
Featured Podcast
Recommended

About

Shop Online

Newsletters

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.